Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Coxsackievirus infection and the development of polymyositis/dermatomyositis.

Literature DB >> 7824834

Coxsackievirus infection and the development of polymyositis/dermatomyositis.

Abstract

Recently, it has been suggested that coxsackievirus plays an etiologic role in juvenile dermatomyositis (DM). Neutralizing antibodies to 12 coxsackievirus antigens were measured in the sera of four clinical subsets of patients with adult polymyositis (PM)/DM. Elevated antibody titers to coxsackievirus A7, B3, and B4 were detected in patients with adult PM, adult DM, and adult PM/DM with malignancy, respectively. The development of these three subsets of idiopathic inflammatory myopathies may be related to infection with specific coxsackievirus serotypes.

Entities: Disease Species

Mesh：

Substances：
Antibodies, Viral

Year: 1994 PMID： 7824834 DOI： 10.1007/bf00300245

Source DB: PubMed Journal: Rheumatol Int ISSN： 0172-8172 Impact factor: 2.631

11 in total

Review 1. Polymyositis and dermatomyositis (first of two parts).

Authors: A Bohan; J B Peter
Journal: N Engl J Med Date: 1975-02-13 Impact factor: 91.245

2. Picornavirus-like crystals in subacute polymyositis.

Authors: S M Chou; L Gutmann
Journal: Neurology Date: 1970-03 Impact factor: 9.910

3. Coxsackie B neutralisation titres in polymyositis/dermatomyositis.

Authors: R L Travers; G R Hughes; G Cambridge; J R Sewell
Journal: Lancet Date: 1977-06-11 Impact factor: 79.321

4. Heterogeneity of precipitating antibodies in polymyositis and dermatomyositis. Characterization of the Jo-1 antibody system.

Authors: M Nishikai; M Reichlin
Journal: Arthritis Rheum Date: 1980-08

5. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis.

Authors: F C Arnett; S M Edworthy; D A Bloch; D J McShane; J F Fries; N S Cooper; L A Healey; S R Kaplan; M H Liang; H S Luthra
Journal: Arthritis Rheum Date: 1988-03

6. Chronic myopathy associated with coxsackievirus type A9. A combined electron microscopical and viral isolation study.

Authors: T T Tang; G V Sedmak; K A Siegesmund; S R McCreadie
Journal: N Engl J Med Date: 1975-03-20 Impact factor: 91.245

7. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee.

Authors:
Journal: Arthritis Rheum Date: 1980-05

Coxsackievirus infection and the development of polymyositis/dermatomyositis.

Review 1. Polymyositis and dermatomyositis (first of two parts).

2. Picornavirus-like crystals in subacute polymyositis.

3. Coxsackie B neutralisation titres in polymyositis/dermatomyositis.

4. Heterogeneity of precipitating antibodies in polymyositis and dermatomyositis. Characterization of the Jo-1 antibody system.

5. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis.

6. Chronic myopathy associated with coxsackievirus type A9. A combined electron microscopical and viral isolation study.

7. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee.

8. The 1982 revised criteria for the classification of systemic lupus erythematosus.

9. Dermatomyositis, polymyositis, and Coxsackie-B-virus infection.

10. Viruses in idiopathic inflammatory myopathies: absence of candidate viral genomes in muscle.

Review 1. Environmental triggers of dermatomyositis: a narrative review.

Review 2. Infections and autoimmunity: a panorama.